- Home
- APGE vs ESAB Comparison
APGE vs ESAB Comparison
Compare APGE & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | ESAB |
|---|---|---|
| Founded | 2022 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.6B |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | APGE | ESAB |
|---|---|---|
| Price | $134.75 | $78.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | $109.67 | ★ $138.56 |
| AVG Volume (30 Days) | ★ 1.2M | 652.7K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $2,842,555,000.00 |
| Revenue This Year | N/A | $6.21 |
| Revenue Next Year | N/A | $5.33 |
| P/E Ratio | ★ N/A | $62.12 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $35.39 | $77.70 |
| 52 Week High | $134.88 | $137.42 |
Technical Indicators
Market Signals| Indicator | APGE | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 77.42 | 35.90 |
| Support Level | $134.03 | N/A |
| Resistance Level | $134.88 | $98.07 |
| Average True Range (ATR) | 0.20 | 3.84 |
| MACD | -0.75 | -1.04 |
| Stochastic Oscillator | 87.65 | 5.19 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.8 billion in revenue in 2025.